Skip to main content

Disorder of Consciousness

0
Pipeline Programs
5
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

ETS
ETSMO - Rolla
2 programs
SECONDs' Italian Translation and Transcultural ValidationN/A1 trial
tDCSN/A1 trial
Active Trials
NCT05714215Unknown60Est. Oct 2023
NCT05929274Withdrawn0Est. Jul 2028
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
BX Pulsar 1002N/A1 trial
Active Trials
NCT04921683Completed16Est. Apr 2023
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Evaluation of the MuSICCA for Measuring AwarenessN/A1 trial
Active Trials
NCT04050995Recruiting80Est. Dec 2027
Neurosteer
NeurosteerIsrael - Tel Aviv
1 program
Transcranial direct current stimulationN/A1 trial
Active Trials
NCT04614792Completed16Est. Dec 2023
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
animal assisted therapyN/A1 trial
Active Trials
NCT02629302Completed10Est. Apr 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
ETStDCS
Temple TherapeuticsEvaluation of the MuSICCA for Measuring Awareness
ETSSECONDs' Italian Translation and Transcultural Validation
Angeles TherapeuticsBX Pulsar 1002
Human BioSciencesanimal assisted therapy
NeurosteerTranscranial direct current stimulation

Clinical Trials (6)

Total enrollment: 182 patients across 6 trials

NCT05929274ETStDCS

Safety and Efficacy of tDCS in Pediatric DoC

Start: Jan 2024Est. completion: Jul 20280
N/AWithdrawn
NCT04050995Temple TherapeuticsEvaluation of the MuSICCA for Measuring Awareness

Evaluation of the MuSICCA for Measuring Awareness

Start: Apr 2022Est. completion: Dec 202780 patients
N/ARecruiting
NCT05714215ETSSECONDs' Italian Translation and Transcultural Validation

SECONDs' Italian Translation and Transcultural Validation

Start: Oct 2021Est. completion: Oct 202360 patients
N/AUnknown
NCT04921683Angeles TherapeuticsBX Pulsar 1002

The Use of LIFUP in Chronic Disorders of Consciousness

Start: Jun 2021Est. completion: Apr 202316 patients
N/ACompleted
NCT02629302Human BioSciencesanimal assisted therapy

Effects of Animal Assisted Therapy on Patients With Severe Disorders of Consciousness

Start: Jan 2016Est. completion: Apr 201710 patients
N/ACompleted
NCT04614792NeurosteerTranscranial direct current stimulation

Excitatory Prefrontal Weak Current Stimulation in Vegetative Patients

Start: Apr 2014Est. completion: Dec 202316 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 182 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.